{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:16:13Z","timestamp":1782458173826,"version":"3.54.5"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Neurofibromatosis type 2 (NF2) is an autosomal-dominant tumor predisposing syndrome that results from mutations in the NF2 tumor suppressor gene on chromosome 22. The development of bilateral vestibular schwannomas is the characteristic feature of the disease. However, other nervous system tumors, including meningiomas, ependymomas, and schwannomas, can be seen frequently. Herein, we present <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/CT findings of 2 siblings with NF2.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004355","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:23Z","timestamp":1660348823000},"page":"e710-e712","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Neurofibromatosis Type 2"],"prefix":"10.1097","volume":"47","author":[{"given":"Nuh","family":"Filizoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Ozguven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","article-title":"Neurofibromatosis type 2","volume":"373","year":"2009","journal-title":"Lancet"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/CCO.0000000000000579","article-title":"Neurofibromatosis type 2 and related disorders","volume":"31","year":"2019","journal-title":"Curr Opin Oncol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-019-02029-5","article-title":"An update on the CNS manifestations of neurofibromatosis type 2","volume":"139","year":"2020","journal-title":"Acta Neuropathol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/B978-0-444-52902-2.00054-0","article-title":"Neurofibromatosis type 2 (NF2): diagnosis and management","volume":"115","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/neuonc\/now001","article-title":"68Gallium-DOTATATE PET in meningioma: a reliable predictor of tumor growth rate?","volume":"18","year":"2016","journal-title":"Neuro Oncol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.2967\/jnumed.117.191932","article-title":"Improved detection of transosseous meningiomas using 68Ga-DOTATATE PET\/CT compared with contrast-enhanced MRI","volume":"58","year":"2017","journal-title":"J Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00259-012-2155-3","article-title":"Detection of cranial meningiomas: comparison of 68Ga-DOTATOC PET\/CT and contrast-enhanced MRI","volume":"39","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2967\/jnumed.114.149120","article-title":"Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue","volume":"56","year":"2015","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:03:28Z","timestamp":1750536208000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004355"}},"subtitle":["Multiple Meningiomatosis and Vestibular Schwannomas on 68Ga-DOTATATE PET\/CT"],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004355","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,16]]}}}